Armstrong AW, Lebwohl M, Warren RB, Sofen H, Morita A, Imafuku S, Ohtsuki M, Spelman L, Passeron T, Papp KA, Colombo MJ, Vaile J, Vritzali E, Hoyt K, Daamen C, Banerjee S, Strober B, Thaçi D, Blauvelt A. Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. J of Skin [Internet]. 2024Jul.23 [cited 2024Sep.20];8(4):s406. Available from: https://dermsquared.com/skin/article/view/2854